Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mullin

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Neurology|August 10, 2005
Increased hippocampal activation in mild cognitive impairment compared to normal aging and ADB C Dickerson, D H Salat, D N Greve, et al.
Human Molecular Genetics|February 19, 2022
Choroidal endothelial and macrophage gene expression in atrophic and neovascular macular degenerationAndrew P Voigt, Nathaniel K Mullin, Kelly Mulfaul, et al.
Journal of Translational Medicine|March 1, 2023
Automating iPSC generation to enable autologous photoreceptor cell replacement therapyLaura R Bohrer, Nicholas E Stone, Nathaniel K Mullin, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Single-Cell Gene Expression and eQTL Analyses in the Human Retina, RPE, and Choroid in Macular DegenerationAndrew P Voigt, Nathaniel K Mullin, Kelly Mulfaul, et al.
Acta Biomaterialia|May 6, 2019
Two-photon polymerized poly(caprolactone) retinal cell delivery scaffolds and their systemic and retinal biocompatibilityJessica R Thompson, Kristan S Worthington, Brian J Green, et al.
The CRISPR Journal|December 18, 2023
CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis PigmentosaErin R Burnight, Luke A Wiley, Nathaniel K Mullin, et al.
Stem Cell Reports|April 18, 2020
Transcriptome Dynamics of Hematopoietic Stem Cell Formation Revealed Using a Combinatorial Runx1 and Ly6a Reporter SystemMichael J Chen, Edroaldo Lummertz da Rocha, Patrick Cahan, et al.
Experimental Hematology|September 16, 2025
A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCsAshlee J Conway, Tolulope O Rosanwo, Thomas E Williamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2025
Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy-Ineligible Patients With Isocitrate Dehydrogenase-Mutated AMLCourtney D DiNardo, Jennifer Marvin-Peek, Sanam Loghavi, et al.
Leukemia|February 25, 2025
Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemiaCourtney D DiNardo, Wei-Ying Jen, Koichi Takahashi, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Neurology|August 10, 2005
Increased hippocampal activation in mild cognitive impairment compared to normal aging and ADB C Dickerson, D H Salat, D N Greve, et al.
Human Molecular Genetics|February 19, 2022
Choroidal endothelial and macrophage gene expression in atrophic and neovascular macular degenerationAndrew P Voigt, Nathaniel K Mullin, Kelly Mulfaul, et al.
Journal of Translational Medicine|March 1, 2023
Automating iPSC generation to enable autologous photoreceptor cell replacement therapyLaura R Bohrer, Nicholas E Stone, Nathaniel K Mullin, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Single-Cell Gene Expression and eQTL Analyses in the Human Retina, RPE, and Choroid in Macular DegenerationAndrew P Voigt, Nathaniel K Mullin, Kelly Mulfaul, et al.
Acta Biomaterialia|May 6, 2019
Two-photon polymerized poly(caprolactone) retinal cell delivery scaffolds and their systemic and retinal biocompatibilityJessica R Thompson, Kristan S Worthington, Brian J Green, et al.
The CRISPR Journal|December 18, 2023
CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis PigmentosaErin R Burnight, Luke A Wiley, Nathaniel K Mullin, et al.
Stem Cell Reports|April 18, 2020
Transcriptome Dynamics of Hematopoietic Stem Cell Formation Revealed Using a Combinatorial Runx1 and Ly6a Reporter SystemMichael J Chen, Edroaldo Lummertz da Rocha, Patrick Cahan, et al.
Experimental Hematology|September 16, 2025
A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCsAshlee J Conway, Tolulope O Rosanwo, Thomas E Williamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2025
Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy-Ineligible Patients With Isocitrate Dehydrogenase-Mutated AMLCourtney D DiNardo, Jennifer Marvin-Peek, Sanam Loghavi, et al.
Leukemia|February 25, 2025
Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemiaCourtney D DiNardo, Wei-Ying Jen, Koichi Takahashi, et al.
Pageof 5